Posts tagged “BDSI”
Raleigh drug firm BDSI takes aim at $1B opioid drug market
"We believe we are on course to become one of the first products to compete with Suboxone, a product with sales in excess of a billion dollars annually and currently without competition," CEO Mark Sirgo says.
BioDelivery Sciences not phased by drug's trial failure
The Raleigh-based company also says potential partners are still interested in the pain reliver.
BioDelivery Sciences drug candidate fails in trial
The chronic pain reliver didn't perform better than a placebo in a Phase 3 clinical trial, but the Raleigh company isn'r giving up.
BioDelivery Sciences prepares for launch of pain killer in Canada
The Raleigh-based drug firm gears to sell breakthrough cancer pain reliver after working through production problems.
Tech briefs: News from SAS, Red Hat, Fast-teks, Tekelec, Metabolon, BioDelivery Sciences, Consultwebs
BioDelivery Sciences secures European approval for pain killer
The decision means $2.5 million in milestone payment for the Raleigh firm.
Former exec at Closure Medical joins BioDelivery Sciences
Benny Ward takes over as business and strategic development director at the drug delivery technology development firm.
BioDelivery Sciences wins Canadian approval for painkiller
The Raleigh-based firm can now sell its “breakthrough” pain killer drug outside of the U.S. It is seeking approval to sell Onsolis in Europe.
BioDelivery Sciences stock plunges after $10M deal disclosed
The announced sale sends BDSI shares down 14 percent from Monday’s closing price of $4.21 per share.
BioDelivery Sciences closing lab in New Jersey, cutting five jobs
Chief science officer is also leaving drug development firm, which recently won FDA approval for its first product.
BioDelivery Sciences wins patent for its breakthrough pain, drug delivery technology
























